Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

The past, present and future use of epidemiological intelligence to plan malaria vector control and parasite prevention in Uganda.

Talisuna AO, Noor AM, Okui AP, Snow RW.

Malar J. 2015 Apr 15;14(1):158. doi: 10.1186/s12936-015-0677-4.

2.

Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.

Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR, Talisuna AO.

PLoS One. 2014 Dec 1;9(12):e113311. doi: 10.1371/journal.pone.0113311. eCollection 2014.

3.

Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.

Kajungu DK, Erhart A, Talisuna AO, Bassat Q, Karema C, Nabasumba C, Nambozi M, Tinto H, Kremsner P, Meremikwu M, D'Alessandro U, Speybroeck N.

PLoS One. 2014 May 1;9(5):e96388. doi: 10.1371/journal.pone.0096388. eCollection 2014.

4.

Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.

Yeka A, Tibenderana J, Achan J, D'Alessandro U, Talisuna AO.

PLoS One. 2013;8(1):e53772. doi: 10.1371/journal.pone.0053772. Epub 2013 Jan 22.

5.

The Affordable Medicines Facility-malaria--a success in peril.

Talisuna AO, Adibaku S, Amojah CN, Amofah GK, Aubyn V, Dodoo A, Juma E, Jackou DH, Mkude S, Okui AP, Ramarosandratana B, Shija SJ.

Malar J. 2012 Nov 8;11:370. doi: 10.1186/1475-2875-11-370.

6.

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.

Talisuna AO, Daumerie PG, Balyeku A, Egan T, Piot B, Coghlan R, Lugand M, Bwire G, Rwakimari JB, Ndyomugyenyi R, Kato F, Byangire M, Kagwa P, Sebisubi F, Nahamya D, Bonabana A, Mpanga-Mukasa S, Buyungo P, Lukwago J, Batte A, Nakanwagi G, Tibenderana J, Nayer K, Reddy K, Dokwal N, Rugumambaju S, Kidde S, Banerji J, Jagoe G.

Malar J. 2012 Oct 29;11:356. doi: 10.1186/1475-2875-11-356.

7.

Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, Mulenga M, Mbacham WF, Roper C, Guerin PJ, D'Alessandro U, Snow RW.

Lancet Infect Dis. 2012 Nov;12(11):888-96. doi: 10.1016/S1473-3099(12)70241-4. Review.

8.

Mobile phone text messaging: tool for malaria control in Africa.

Zurovac D, Talisuna AO, Snow RW.

PLoS Med. 2012 Feb;9(2):e1001176. doi: 10.1371/journal.pmed.1001176. Epub 2012 Feb 21. No abstract available.

9.

Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.

Guech-Ongey M, Yagi M, Palacpac NM, Emmanuel B, Talisuna AO, Bhatia K, Stefan DC, Biggar RJ, Nkrumah F, Neequaye J, Tougan T, Horii T, Mbulaiteye SM.

Int J Cancer. 2012 Apr 15;130(8):1908-14. doi: 10.1002/ijc.26203. Epub 2011 Aug 8.

10.

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U.

Malar J. 2011 May 24;10:144. doi: 10.1186/1475-2875-10-144. Review.

11.

Increasing malaria hospital admissions in Uganda between 1999 and 2009.

Okiro EA, Bitira D, Mbabazi G, Mpimbaza A, Alegana VA, Talisuna AO, Snow RW.

BMC Med. 2011 Apr 13;9:37. doi: 10.1186/1741-7015-9-37.

12.

Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.

Baliraine FN, Nsobya SL, Achan J, Tibenderana JK, Talisuna AO, Greenhouse B, Rosenthal PJ.

Antimicrob Agents Chemother. 2011 Feb;55(2):615-22. doi: 10.1128/AAC.00954-10. Epub 2010 Nov 15.

13.

Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008.

Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, Amone J, Mbabazi W, Nanyunja M, Zaramba S, Opio A, Lutwama JJ, Talisuna AO, Okware SI.

Emerg Infect Dis. 2010 Jul;16(7):1087-92. doi: 10.3201/eid1607.091525.

14.

African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?

Mbulaiteye SM, Talisuna AO, Ogwang MD, McKenzie FE, Ziegler JL, Parkin DM.

Lancet. 2010 May 8;375(9726):1661-3. doi: 10.1016/S0140-6736(10)60134-1. No abstract available.

PMID:
20452522
15.

Implementing Integrated Disease Surveillance and Response: Four African countries' experience, 1998-2005.

Nsubuga P, Brown WG, Groseclose SL, Ahadzie L, Talisuna AO, Mmbuji P, Tshimanga M, Midzi S, Wurapa F, Bazeyo W, Amri M, Trostle M, White M.

Glob Public Health. 2010;5(4):364-80. doi: 10.1080/17441690903334943.

PMID:
19916090
16.

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO.

BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.

17.

Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?

Yeka A, Achan J, D'Alessandro U, Talisuna AO.

Lancet Infect Dis. 2009 Jul;9(7):448-52. doi: 10.1016/S1473-3099(09)70109-4. Review.

PMID:
19555904
18.

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Bukirwa H, Nayiga S, Lubanga R, Mwebaza N, Chandler C, Hopkins H, Talisuna AO, Staedke SG.

Trop Med Int Health. 2008 Sep;13(9):1143-52. doi: 10.1111/j.1365-3156.2008.02119.x. Epub 2008 Jul 8.

19.

Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.

Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO.

Malar J. 2008 Jun 11;7:107. doi: 10.1186/1475-2875-7-107.

20.

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.

Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG.

Malar J. 2008 Jun 11;7:106. doi: 10.1186/1475-2875-7-106.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk